SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 136 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,728 | +17.4% | 22,508 | +10.9% | 0.02% | +12.5% |
Q2 2023 | $2,323 | -30.8% | 20,288 | -16.6% | 0.02% | -30.4% |
Q1 2023 | $3,355 | +9.9% | 24,338 | +3.3% | 0.02% | +4.5% |
Q4 2022 | $3,052 | -99.9% | 23,554 | -13.5% | 0.02% | 0.0% |
Q3 2022 | $3,009,000 | +205.2% | 27,224 | +106.9% | 0.02% | +214.3% |
Q2 2022 | $986,000 | -26.6% | 13,158 | -23.5% | 0.01% | 0.0% |
Q1 2022 | $1,343,000 | +3.8% | 17,195 | +19.6% | 0.01% | +16.7% |
Q4 2021 | $1,294,000 | +18.9% | 14,375 | +22.1% | 0.01% | 0.0% |
Q3 2021 | $1,088,000 | +44.7% | 11,770 | +21.7% | 0.01% | +50.0% |
Q2 2021 | $752,000 | -47.9% | 9,672 | -50.1% | 0.00% | -50.0% |
Q1 2021 | $1,444,000 | -53.3% | 19,371 | +6.9% | 0.01% | -57.9% |
Q4 2020 | $3,091,000 | +74.5% | 18,128 | +43.8% | 0.02% | +72.7% |
Q3 2020 | $1,771,000 | -63.0% | 12,608 | -57.8% | 0.01% | -71.8% |
Q2 2020 | $4,786,000 | +465.1% | 29,849 | +244.9% | 0.04% | +333.3% |
Q1 2020 | $847,000 | -25.0% | 8,655 | -1.2% | 0.01% | 0.0% |
Q4 2019 | $1,130,000 | +71.7% | 8,757 | +0.2% | 0.01% | +50.0% |
Q3 2019 | $658,000 | -44.3% | 8,742 | +19.4% | 0.01% | -25.0% |
Q3 2018 | $1,182,000 | -28.2% | 7,320 | -41.2% | 0.01% | -20.0% |
Q2 2018 | $1,646,000 | +63.8% | 12,450 | -8.2% | 0.01% | +42.9% |
Q1 2018 | $1,005,000 | -12.0% | 13,566 | -33.9% | 0.01% | -12.5% |
Q4 2017 | $1,142,000 | +414.4% | 20,528 | +319.2% | 0.01% | +700.0% |
Q3 2017 | $222,000 | -23.2% | 4,897 | +3.9% | 0.00% | -50.0% |
Q3 2016 | $289,000 | +151.3% | 4,712 | -21.9% | 0.00% | +100.0% |
Q2 2016 | $115,000 | +10.6% | 6,034 | +13.6% | 0.00% | 0.0% |
Q1 2016 | $104,000 | -31.1% | 5,310 | +35.5% | 0.00% | 0.0% |
Q4 2015 | $151,000 | -2.6% | 3,918 | -18.9% | 0.00% | 0.0% |
Q3 2015 | $155,000 | +229.8% | 4,833 | +216.1% | 0.00% | – |
Q2 2015 | $47,000 | +193.8% | 1,529 | +28.6% | 0.00% | – |
Q1 2015 | $16,000 | -5.9% | 1,189 | +0.9% | 0.00% | – |
Q4 2014 | $17,000 | -41.4% | 1,178 | -14.9% | 0.00% | – |
Q3 2014 | $29,000 | -27.5% | 1,385 | +3.4% | 0.00% | – |
Q2 2014 | $40,000 | +25.0% | 1,340 | 0.0% | 0.00% | – |
Q1 2014 | $32,000 | +33.3% | 1,340 | +12.7% | 0.00% | – |
Q4 2013 | $24,000 | -86.9% | 1,189 | -69.3% | 0.00% | -100.0% |
Q3 2013 | $183,000 | +134.6% | 3,873 | +88.0% | 0.00% | +100.0% |
Q2 2013 | $78,000 | – | 2,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |